2024-10-24 - Analysis Report
## Intuitive Surgical Inc (ISRG) Stock Analysis

**Company Overview:** Intuitive Surgical Inc is a leading developer and manufacturer of robotic-assisted surgical systems and related instruments. 

**Performance Analysis:**

1. **Relative Performance:** ISRG has significantly outperformed the S&P 500 (VOO) with a cumulative return of 374.1 compared to 136.39 for VOO. The current relative performance is 237.71, which means ISRG's performance is 81.88% higher than VOO, based on historical data.

2. **Recent Price Movement:** 
    * Closing Price: $516.78
    * 5-day Moving Average: $501.42
    * 20-day Moving Average: $488.15
    * 60-day Moving Average: $479.65

The stock is currently trading above its 5, 20, and 60-day moving averages, suggesting upward momentum.

3. **Technical Indicators:**
    * RSI (Relative Strength Index): 63.31. This suggests the stock is in overbought territory, but it is not yet in a strong sell signal zone.
    * PPO (Percentage Price Oscillator): 0.75. A positive PPO value indicates a potential uptrend.
    * Delta_Previous_Relative_Divergence: 6.87. A positive value indicates a potential uptrend based on recent price movement.
    * Expected Return: 12.4%. This is the projected long-term (2+ years) excess return over the S&P 500, based on current conditions.

4. **Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2024-10-18 | 1.18 | 1.74 B$ |

The most recent earnings (2024-10-18) showed strong results with an EPS of 1.59 exceeding expectations. Revenue also surpassed estimates, indicating strong demand for ISRG's products. Analysts expect continued growth in both EPS and revenue in the coming quarters, driven by expanding market share and increasing adoption of robotic surgery.

5. **News and Recent Issues:**

* **Recent Market Outlook:** The market outlook for ISRG is positive, with analysts citing strong demand for robotic surgery and continued growth in the medical device industry.
* **Analyst Opinions:**  Several analysts have upgraded ISRG to "Buy" or "Outperform" recently, citing strong fundamentals, attractive valuation, and a robust pipeline of new products.
* **Performance Highlights:** ISRG continues to dominate the robotic surgery market with a strong market share and a significant competitive advantage. The company has been investing heavily in research and development, ensuring its leading position in the industry.

**Overall Analysis:**

Intuitive Surgical is a strong performer with a positive outlook. The company has demonstrated consistent growth in both revenue and earnings, and is well-positioned to benefit from the long-term trend of increasing adoption of robotic surgery. While the stock is currently trading in overbought territory, the strong fundamentals and growth potential suggest continued upside potential. Investors looking for exposure to the medical device industry with a long-term horizon may consider ISRG for their portfolio. 
